ResMed (NYSE:RMD) intends to keep its CPAP masks that utilize magnets on the market despite a recall because it regards the action as a labeling correction rather than a product removal. According to ...

Resmed has received clearance from the U.S. Food and Drug Administration (FDA) for an artificial intelligence (AI)-enabled ...

Please provide your email address to receive an email when new articles are posted on . ResMed CPAP masks that contain magnets are being recalled due to possible magnetic interference with medical ...

ResMed (NYSE:RMD) said it is updating the guides for all of its masks with magnets to alert users to potential magnetic interference with certain medical devices and implants. ResMed said that the ...

Resmed (NYSE: RMD) announced today that it received FDA clearance for its Smart Comfort personalized therapy comfort settings ...

Jan 16 (Reuters) - ResMed (RMD.N), opens new tab said its respiratory masks containing magnets will remain on the market even though the U.S. Food and Drug Administration classified a recall of the ...

SAN DIEGO, Dec. 20, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) is conducting a voluntary global field action to update its guides for all masks with magnets to inform users about potential ...

Nearly 2 to 1 patients prefer AirFit F30 over the current minimal-contact full face market leader SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD, ASX: RMD) today announced the availability of its first ...

We maintain our USD 258 fair value estimate for narrow-moat ResMed RMD, or AUD 40 per CDI at current exchange rates, following first-quarter fiscal 2024 results. Underlying EBIT of USD 319 million ...

Resmed Inc. RMD continues to see strong demand for its market-leading mask portfolio, including AirFit, AirTouch and other ranges. The company often relies on strategic acquisitions to strengthen its ...